SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-22-002810
Filing Date
2022-02-01
Accepted
2022-02-01 18:05:49
Documents
1
Period of Report
2022-01-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3069
  Complete submission text file 0001127602-22-002810.txt   4434
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 BOYLSTON ST., SUITE 3310 PRUDENTIAL TOWER C/O AJU IB INVESTMENT BOSTON MA 02199
Business Address
Sullivan Timothy Eugene (Reporting) CIK: 0001707000 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 22580512